Get the tools used by (smart)² investors.

Watchlists Ideas Screener Data Explorer Charts Saved Work

Cash Flow to Current Liabilities for Vyne Therapeutics Inc

Join now and get access to the full platform

Search for company or ETF

0 results available. Select is focused ,type to refine list, press Down to open the menu,

VYNE: Vyne Therapeutics Inc

VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company’s lead program is repibres...

1.43 USD

Price

– USD

Fair Value

–

Upside

1.28 - 4.30

52-week range

Create Chart Create Model Add To Watchlist

Analysis

Fiscal Years

Trailing Twelve Months

Fiscal Halfs

Fiscal Quarters

Daily

Hide this widget

The following section summarizes insights on Vyne Therapeutics Inc's Cash Flow to Current Liabilities:

Performance Summary

Vyne Therapeutics's latest twelve months cash flow to current liabilities is -303.9%
Vyne Therapeutics's cash flow to current liabilities for fiscal years ending December 2020 to 2024 averaged -326.3%.
Vyne Therapeutics's operated at median cash flow to current liabilities of -300.2% from fiscal years ending December 2020 to 2024.
Looking back at the last 5 years, Vyne Therapeutics's cash flow to current liabilities peaked in December 2022 at -210.4%.
Vyne Therapeutics's cash flow to current liabilities hit its 5-year low in December 2020 of -536.6%.
Vyne Therapeutics's cash flow to current liabilities decreased in 2020 (-536.6%, +45.5%), 2023 (-300.2%, +42.7%), and 2024 (-303.9%, +1.2%) and increased in 2021 (-280.6%, -47.7%) and 2022 (-210.4%, -25.0%).

Benchmarks

Metric Usage: Cash Flow to Current Liabilities

Hide this widget

ocf_to_liabilities_cur

Slug

number

Datatype

text

Format

current

Default Period

FY, LTM

Periods Supported

Free

Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Cash Flow to Current Liabilities in the risk category include:

Equity / Total Assets - A ratio that measures a company's book value of total equity as a percentage of total assets.
Interest Coverage Ratio - A ratio used to assess a firm's ability to pay interest expenses based on operating profits (EBIT).
Net Debt / Total Capital - A ratio that measures the level of the net debt relative to the market value of total capital. Net debt is the sum of all long term debt fields minus cash and short-term investments.
Total Liabilities / Total Assets - A ratio that measures the proportion of a firm's assets financed by liabilities.

View Full List

Search for metric or datapoint

Cash Flow to Current Liabilities

A ratio that measures the amount of operating cash flow a firm generates on each dollar of current liabilities.

Definition of Cash Flow to Current Liabilities

Hide this widget

A ratio that measures the amount of operating cash flow a firm generates on each dollar of current liabilities.

Sector Benchmark Analysis

Sector

Industry Group

Industry

Hide this widget

The chart above depicts the distribution of cash flow to current liabilities for companies operating in the Healthcare sector in the Developed economic region. Over 2,290 companies were considered in this analysis, and 2,201 had meaningful values. The average cash flow to current liabilities of companies in the sector is -134.9% with a standard deviation of 213.1%.

Vyne Therapeutics Inc's Cash Flow to Current Liabilities of -303.9% ranks in the 21.8% percentile for the sector. The following table provides additional summary stats:

Cash Flow to Current Liabilities In The Healthcare Sector
Economic Risk Region	Developed
Total Constituents	2,293
Included Constituents	2,201
Min	-867.9%
Max	172.1%
Median	-47.4%
Mean	-134.9%
Standard Deviation	213.1%

You can find companies with similar cash flow to current liabilities using this stock screener.